---
kind: "section"
citation: "42 C.F.R. § 414.900"
title: "42"
number: "414.900"
heading: "Basis and scope."
url: "https://uscodex.org/cfr/42/414.900"
---

# §414.900. Basis and scope.

- (a) This subpart implements sections 1842(o), 1847A, and 1847B of the Act and outlines two payment methodologies applicable to drugs and biologicals covered under Medicare Part B that are not paid on a cost or prospective payment system basis.
- (b) **Examples of drugs that are subject to the requirements specified in this subpart are—**
  - (1) **Drugs furnished incident to a physician's service; durable medical equipment (DME) drugs.**
  - (2) **Separately billable drugs at independent dialysis facilities not under the ESRD composite rate.**
  - (3) **Statutorily covered drugs, for example—**
    - (i) **Influenza.**
    - (ii) **Pneumococcal, Hepatitis B, and COVID-19 vaccines.**
    - (iii) **Antigens.**
    - (iv) **Hemophilia blood clotting factor.**
    - (v) **Immunosuppressive drugs.**
    - (vi) **Certain oral anti-cancer drugs.**

## Notes

### Amendments

[69 FR 66424, Nov. 15, 2004, as amended at 70 FR 39093, July 6, 2005; 85 FR 71197, Nov. 6, 2020]

### Source

Source: 69 FR 66424, Nov. 15, 2004, unless otherwise noted.

### Authority

Authority: 42 U.S.C. 1302, 1395hh, and 1395rr(b)(l).

### Source

Source: 55 FR 23441, June 8, 1990, unless otherwise noted.

### Amendments

[69 FR 66424, Nov. 15, 2004, as amended at 70 FR 39093, July 6, 2005; 85 FR 71197, Nov. 6, 2020]